Olivier Boulesteix, Jérémy Pezant, Sylvie Attucci, Christelle Rossignol, Déborah Bréa, Claire Chevaleyre, Francis Gauthier, Patricia Berthon, Sandrine Melo, Michel Olivier, Frédéric Becq, Mickaël Riou, Clarisse Vandebrouck, Mustapha Berri, Ignacio Caballero-Posadas, Mustapha Si-Tahar, Julien Gaillard, Céline Barc, Rémy Delaunay, François Meurens, UR Infectiologie animale et Santé publique (UR IASP), Institut National de la Recherche Agronomique (INRA), Plateforme d'Infectiologie Expérimentale (PFIE - INRA UE 1277), Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 (CEPR), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), Signalisation et Transports Ioniques Membranaires (STIM), Université de Poitiers-Université de Tours-Centre National de la Recherche Scientifique (CNRS), Département des Microscopies, Université Francois Rabelais [Tours], Identités, Cultures, Territoires (ICT (EA_337)), Université Paris Diderot - Paris 7 (UPD7), Bioagression, Epidémiologie et Analyse de Risques (BIOEPAR), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire de Nantes, Attucci, Sylvie, Infectiologie et Santé Publique (UMR ISP), Institut National de la Recherche Agronomique (INRA)-Université de Tours (UT), Plateforme d'Infectiologie Expérimentale (PFIE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Poitiers-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA)-Université de Tours, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Tours, Université de Tours-Université de Poitiers-Centre National de la Recherche Scientifique (CNRS), Biologie, Epidémiologie et analyse de risque en Santé Animale (BIOEPAR), Institut National de la Recherche Agronomique (INRA)-École nationale vétérinaire, agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS), Morillon, Christelle, Université de Tours (UT)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Université de Tours (UT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Tours (UT), PPF 'Analyses des Systèmes Biologiques', and Ecole Nationale Vétérinaire, Agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS)
International audience; The main features of lung infection and inflammation are a massive recruitment of neutrophils and the subsequent release of neutrophil serine proteases (NSPs). Anti-infectious and/or anti-inflammatory treatments must be tested on a suitable animal model. Mice models do not replicate several aspects of human lung disease. This is particularly true for cystic fibrosis (CF), which has led the scientific community to a search for new animal models. We have shown that mice are not appropriate for characterizing drugs targeting neutrophil-dependent inflammation and that pig neutrophils and their NSPs are similar to their human homologues. We induced acute neutrophilic inflammatory responses in pig lungs using Pseudomonas aeruginosa, an opportunistic respiratory pathogen. Blood samples, nasal swabs and bronchoalveolar lavage fluids (BALFs) were collected at 0, 3, 6 and 24 h post-insfection (p.i.) and biochemical parameters, serum and BAL cytokines, bacterial cultures and neutrophil activity were evaluated. The release of proinflammatory mediators, biochemical and hematological blood parameters, cell recruitment and bronchial reactivity, peaked at 6h p.i.. We also used synthetic substrates specific for human neutrophil proteases to show that the activity of pig NSPs in BALFs increased. These proteases were also detected at the surface of lung neutrophils using anti-human NSP antibodies. Pseudomonas aeruginosa-induced lung infection in pigs results in a neutrophilic response similar to that described for cystic fibrosis and ventilator-associated pneumonia in humans. Altogether, this indicates that the pig is an appropriate model for testing anti-infectious and/or anti-inflammatory drugs to combat adverse proteolytic effects of neutrophil in human lung diseases.